相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition
Housam Eidi et al.
BMC MEDICINE (2015)
Genetic basis of autoimmunity
Alexander Marson et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life
Beatris Mastelic Gavillet et al.
JOURNAL OF IMMUNOLOGY (2015)
Cholera Toxin, and the Related Nontoxic Adjuvants mmCT and dmLT, Promote Human Th17 Responses via Cyclic AMP-Protein Kinase A and Inflammasome-Dependent IL-1 Signaling
Maximilian Larena et al.
JOURNAL OF IMMUNOLOGY (2015)
Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection
Yoshikazu Honda-Okubo et al.
VACCINE (2015)
A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection
Estela Rodriguez-Del Rio et al.
VACCINE (2015)
Aluminium in Allergies and Allergen immunotherapy
Erika Jensen-Jarolim
WORLD ALLERGY ORGANIZATION JOURNAL (2015)
Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
Gerald Aichinger et al.
CLINICAL AND VACCINE IMMUNOLOGY (2015)
Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
Yoshikazu Honda-Okubo et al.
JOURNAL OF VIROLOGY (2015)
Assessment of benefits and risks in development of targeted therapies for cancer - The view of regulatory authorities
Francesco Pignatti et al.
MOLECULAR ONCOLOGY (2015)
Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes
Bradford S. Powell et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2015)
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system
Andre Barkhordarian et al.
BIOINFORMATION (2015)
Advax-Adjuvanted Recombinant Protective Antigen Provides Protection against Inhalational Anthrax That Is Further Enhanced by Addition of Murabutide Adjuvant
Brandon Feinen et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts
Calvin C. Willhite et al.
CRITICAL REVIEWS IN TOXICOLOGY (2014)
Danger, diversity and priming in innate antiviral immunity
Susan E. Collins et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Shortcomings of pertussis vaccines: why we need a third generation vaccine
Jan T. Poolman
EXPERT REVIEW OF VACCINES (2014)
Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?
Christopher A. Shaw et al.
IMMUNOTHERAPY (2014)
Th17 and Non-Classic Th1 Cells in Chronic Inflammatory Disorders: Two Sides of the Same Coin
Lorenzo Cosmi et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2014)
Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants
S. Sohail Ahmed et al.
JOURNAL OF AUTOIMMUNITY (2014)
Glucosamine Dose/Concentration-Effect Correlation in the Rat with Adjuvant Arthritis
Ali Aghazadeh-Habashi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Arthritis, a complex connective and synovial joint destructive autoimmune disease: Animal models of arthritis with varied etiopathology and their significance
S. R. Naik et al.
JOURNAL OF POSTGRADUATE MEDICINE (2014)
The amphiphilic nature of saponins and their effects on artificial and biological membranes and potential consequences for red blood and cancer cells
Joseph H. Lorent et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk
Outi Vaarala et al.
PLOS ONE (2014)
Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study
A. Spadea et al.
VACCINE (2014)
Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination
Josianne Nitcheu Tefit et al.
VACCINE (2014)
Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study
David Gordon et al.
VACCINE (2014)
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
Julia Scheiermann et al.
VACCINE (2014)
Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere Trivalent Influenza Vaccine is associated with adverse events
Steve Rockman et al.
VACCINE (2014)
Aluminium in allergen-specific subcutaneous immunotherapy - A German perspective
Matthias F. Kramer et al.
VACCINE (2014)
A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection
Yoshikazu Honda-Okubo et al.
VACCINE (2014)
Ethical considerations in post-market-approval monitoring and regulation of vaccines
Alison Thompson et al.
VACCINE (2014)
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
Jaap T. van Dissel et al.
VACCINE (2014)
Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods
Daniela Fanni et al.
WORLD JOURNAL OF PEDIATRICS (2014)
Intranasal Vaccination Promotes Detrimental Th17Mediated Immunity against Influenza Infection
Asher Maroof et al.
PLOS PATHOGENS (2014)
Clinical features in patients with long-lasing macrophagic myofasciitis
Muriel Rigolet et al.
FRONTIERS IN NEUROLOGY (2014)
Does Allergen-specific Immunotherapy Induce Contact Allergy to Aluminium?
Eva Netterlid et al.
ACTA DERMATO-VENEREOLOGICA (2013)
Predictive markers of safety and immunogenicity of adjuvanted vaccines
Beatris Mastelic et al.
BIOLOGICALS (2013)
Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death
Heriberto Lima et al.
CELL CYCLE (2013)
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum
Olga Vera-Lastra et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)
Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine
Kae Pusic et al.
FASEB JOURNAL (2013)
Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity
C. A. Shaw et al.
IMMUNOLOGIC RESEARCH (2013)
Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes
C. A. Shaw et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody
Nikolai Petrovsky et al.
JOURNAL OF VIROLOGY (2013)
Treating inflammation by blocking interleukin-1 in humans
Charles A. Dinarello et al.
SEMINARS IN IMMUNOLOGY (2013)
A global regulatory science agenda for vaccines
Lindsay Elmgren et al.
VACCINE (2013)
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-4018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age
William L. Heyward et al.
VACCINE (2013)
Provider dismissal policies and clustering of vaccine-hesitant families An agent-based modeling approach
Alison M. Buttenheim et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Rethinking vaccine policy making in an era of vaccine hesitancy Time to rebuild, not remodel?
Douglas J. Opel et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
How society should respond to the risk of vaccine rejection
David Ropeik
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Adjuvants for human vaccines
Carl R. Alving et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Hypersensitivity Reactions to Vaccine Constituents: A Case Series and Review of the Literature
Jonathan S. Leventhal et al.
DERMATITIS (2012)
Induction of decreased fecundity by tetanus toxoid hyper-immunization in C57BL/6 mice depends on the applied adjuvant
Irena Zivkovic et al.
INNATE IMMUNITY (2012)
Oily adjuvants and autoimmunity: now time for reconsideration?
M. Whitehouse
LUPUS (2012)
Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld's syndrome)
O. Vera-Lastra et al.
LUPUS (2012)
Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland
Markku Partinen et al.
PLOS ONE (2012)
AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
Hanna Nohynek et al.
PLOS ONE (2012)
Cell Recruitment and Cytokines in Skin Mice Sensitized with the Vaccine Adjuvants: Saponin, Incomplete Freund's Adjuvant, and Monophosphoryl Lipid A
Juliana Vitoriano-Souza et al.
PLOS ONE (2012)
Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages
Kate Schroder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine
Benjamin P. Sablan et al.
VACCINE (2012)
A genomics-based approach to assessment of vaccine safety and immunogenicity in children
Olivia J. White et al.
VACCINE (2012)
Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo
Marina Zaitseva et al.
VACCINE (2012)
Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age
Scott A. Halperin et al.
VACCINE (2012)
Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
David L. Gordon et al.
VACCINE (2012)
Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses
Yoshikazu Honda-Okubo et al.
VACCINE (2012)
Overview of global regulatory toxicology requirements for vaccines and adjuvants
Yuansheng Sun et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Carbohydrate-based immune adjuvants
Nikolai Petrovsky et al.
EXPERT REVIEW OF VACCINES (2011)
Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2→1] poly(fructo-furanosyl) α-D-glucose polymers
Peter D. Cooper et al.
GLYCOBIOLOGY (2011)
Consent and public engagement in an era of expanded childhood immunisation
Julie Leask et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2011)
A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720
James S. McCarthy et al.
PLOS ONE (2011)
Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy
Theodore F. Tsai et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2011)
Pandemic influenza A (H1N1) vaccination in The Netherlands: Parental reasoning underlying child vaccination choices
Marloes Bults et al.
VACCINE (2011)
Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults
Christine B. Turley et al.
VACCINE (2011)
Heat-Labile Enterotoxins as Adjuvants or Anti-Inflammatory Agents
Shuang Liang et al.
IMMUNOLOGICAL INVESTIGATIONS (2010)
An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
Mario Lobigs et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Flagellin as an Adjuvant: Cellular Mechanisms and Potential
Steven B. Mizel et al.
JOURNAL OF IMMUNOLOGY (2010)
Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults
John J. Treanor et al.
VACCINE (2010)
Intralysosomal Iron Induces Lysosomal Membrane Permeabilization and Cathepsin D-Mediated Cell Death in Trabecular Meshwork Cells Exposed to Oxidative Stress
Yizhi Lin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
Arnaud M. Didierlaurent et al.
JOURNAL OF IMMUNOLOGY (2009)
Regulators face tough flu-jab choices
Declan Butler
NATURE (2009)
Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin
David J. M. Lewis et al.
PLOS ONE (2009)
Parental Refusal of Pertussis Vaccination Is Associated With an Increased Risk of Pertussis Infection in Children
Jason M. Glanz et al.
PEDIATRICS (2009)
Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants
Vishukumar Aimanianda et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Freeing vaccine adjuvants from dangerous immunological dogma
Nikolai Petrovsky
EXPERT REVIEW OF VACCINES (2008)
CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway
Wen Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Vaccination-induced systemic autoimmunity in farmed Atlantic salmon
Erling O. Koppang et al.
JOURNAL OF IMMUNOLOGY (2008)
CD4+ T cell-specific deletion of IL-4 receptor α prevents ovalbumin-induced anaphylaxis by an IFN-γ-dependent mechanism
Natalie Nieuwenhuizen et al.
JOURNAL OF IMMUNOLOGY (2007)
TLR9 signaling in B cells determines class switch recombination to IgG2a
Andrea Jegerlehner et al.
JOURNAL OF IMMUNOLOGY (2007)
Toll-like receptor signalling and the clinical benefits that lie within
B. Verstak et al.
INFLAMMATION RESEARCH (2007)
Vaccination of Alzheimer's model mice with Aβ derivative in alum adjuvant reduces Aβ burden without microhemorrhages
Ayodeji A. Asuni et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis
Caroline Sutton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Influenza and the challenge for immunology
PC Doherty et al.
NATURE IMMUNOLOGY (2006)
Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults
SA Halperin et al.
VACCINE (2006)
Therapeutic potential of Toll-like receptor 9 activation
Arthur M. Krieg
NATURE REVIEWS DRUG DISCOVERY (2006)
Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey
F Verdier et al.
VACCINE (2005)
Adjuvants and antibody production: Dispelling the myths associated with Freund's complete and other adjuvants
HF Stills
ILAR JOURNAL (2005)
Distinctive patterns of autoimmune response induced by different types of mineral oil
Y Kuroda et al.
TOXICOLOGICAL SCIENCES (2004)
Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration
M Heikenwalder et al.
NATURE MEDICINE (2004)
ISCOMATRIX™ adjuvant:: an adjuvant suitable for use in anticancer vaccines
TJ Stewart et al.
VACCINE (2004)
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
ID Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Adjuvant oil induces waves of arthritogenic lymph node cells prior to arthritis onset
BC Holm et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Oligodeoxynucleotides containing CpG motifs can induce T cell-dependent arthritis in rats
L Svelander et al.
ARTHRITIS AND RHEUMATISM (2004)
Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-Class CpG oligodeoxynucleotide TLR9 agonist
AM Krieg et al.
JOURNAL OF IMMUNOTHERAPY (2004)
A global perspective on vaccine safety and public health: The global advisory committee on vaccine safety
PI Folb et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2004)
CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B® HBV vaccine in healthy adults:: A double-blind phase I/II study
CL Cooper et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2004)
Vaccine adjuvants: Current state and future trends
N Petrovsky et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Fibrosarcomas at presumed sites of injection in dogs: Characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas
M Vascellari et al.
JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE (2003)
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo et al.
NEUROLOGY (2003)
CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells
A Krug et al.
JOURNAL OF IMMUNOLOGY (2003)
Aluminum inclusion macrophagic myofasciitis: a recently identified condition
RK Gherardi et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2003)
Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection
RL de Swart et al.
JOURNAL OF VIROLOGY (2002)
Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome
HM Hoffman et al.
NATURE GENETICS (2001)
Immunopathogenesis of vaccine-enhanced RSV disease
PJM Openshaw et al.
VACCINE (2001)
Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle
RK Gherardi et al.
BRAIN (2001)
Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21
DC Waite et al.
VACCINE (2001)
Central nervous system disease in patients with macrophagic myofasciitis
FJ Authier et al.
BRAIN (2001)
Beryllium, an adjuvant that promotes gamma interferon production
JY Lee et al.
INFECTION AND IMMUNITY (2000)
Critical contribution of liver natural killer T cells to a murine model of hepatitis
K Takeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
G Hartmann et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
